Product Image

Potassium Amino Acid Complex

Solgar
4.6
★ ★ ★ ★ ★
(135 ratings)
Potassium 99 mg
Product Image
Score77
Chelated potassium and a simple tablet format are useful, but the small amount and limited yield detail cap its value.
How scoring works
Quantity:100 Tablet(s) • (100 servings)
Goals:
Heart Health

Score 77

Chelated potassium and a simple tablet format are useful, but the small amount and limited yield detail cap its value.
How scoring works
$10.34($0.10 per serving)
Vitacost
$ 10.57
Pure Formulas
$ 10.34
Daily Vita
$ 11.40
iHerb
$ 10.34
Walmart
$ 12.73
Report prices

Analysis

The glycinate amino acid complex is a favorable disclosed form for a small potassium serving. At 99 mg, it contributes little toward typical daily intake.

Its focused composition is easy to assess and may complement a potassium-rich diet. The single ingredient does not address broader cardiovascular pathways.

A tablet format supports consistent dosing without the measuring demands of powder. The label would be clearer if it separated complex weight from elemental potassium yield.

Who is it for
  • Adults who prefer chelated mineral forms
  • People seeking a controlled low-dose tablet
Best for
  • Low-dose potassium support
  • Simple daily supplementation

Pros

  • Favorable glycinate complex
  • Clearly listed active amount
  • Convenient tablet format

Cons

  • Low potassium potency
  • Elemental yield is not separately stated
  • No broader heart-health ingredients

Warnings

  • The 99 mg potassium serving may be unsuitable with impaired kidney function because potassium can accumulate.
  • ACE inhibitors, ARBs, and potassium-sparing diuretics can increase the risk of excessive blood potassium.
  • Taking potassium without enough fluid or food may cause stomach irritation in sensitive users.

Nutrient quality

79 High impact

A potassium glycinate amino acid complex provides a high-quality chelated source. The elemental amount is too small for substantial potassium support, while the low amount avoids obvious excess in healthy adults.

Ingredient transparency

78 High impact

The chelated source and amount are clear, though compound weight and elemental yield are not separated. Serving totals are apparent, but full directions and inactive ingredients are not supplied.

Customer satisfaction

63 Moderate impact

The supplied average rating is favorable. The moderate rating base offers some confidence but is not extensive, while complaint and firsthand experience details are unavailable.

Value for money

86 Highest impact

Formula quality provides partial support for the asking position. The serving value is reasonably competitive within the category.

Report analysis

Goals

Impact
Moderate effect
C Goal FitD+ Strength of SupportF CoverageA+ Formula Quality

Potassium supports sodium balance and normal blood-pressure physiology, but the 99 mg amount is very small. The focused formula is relevant to one cardiovascular pathway without claiming broader mechanisms.

A glycinate amino acid complex is a favorable disclosed form. The low amount limits practical contribution despite good transparency and a streamlined label.

Study evidence
Potassium Supportive 182 studies

Ingredients

IngredientAmount per serving
Potassium (Potassium Glycinate Amino Acid Complex)
99 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Sugar Free Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyD+ Value

Potassium glycinate amino acid complex is a high-quality chelated form, but the 99 mg serving is low. The amount is easy to identify, while the compound weight and elemental yield are not separately shown. Very low serving cost provides fair value for users who specifically want a small supplemental dose.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  2. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  3. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S; PURE Investigators · BMJ (Clinical research ed.) · 2019
    Cohort study103,570 participantsHeart Health forPotassium
  4. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  5. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
    Kawano Y; Minami J; Takishita S; Omae T · American journal of hypertension · 1999
    Randomized trial55 participantsHeart Health forPotassium